Health Tech, MedCity Influencers, Artificial Intelligence IBM dumping Watson Health is an opportunity to reevaluate artificial intelligence By Shravani Durbhakula
MedCity Influencers, Opinion, Artificial Intelligence Why IBM Watson Health could never live up to the promises By John Frownfelter
Artificial Intelligence, Health Tech Will IBM’s reported desire to sell Watson cast a shadow over big tech’s healthcare ambitions? By Elise Reuter
Payers, Artificial Intelligence, Health Tech Humana, IBM Watson Health team up to provide access to AI chatbot By Anuja Vaidya
BioPharma, Artificial Intelligence Watson for Drug Discovery may be down, but AI in biopharma isn’t out By Alaric DeArment
Artificial Intelligence, Pharma Report: IBM is ending sales of Watson for Drug Discovery By Erin Dietsche
Payers Aon potentially looking to acquire Willis Tower Watson to create world’s largest brokerage company By Kevin Truong
Artificial Intelligence, Hospitals IBM Watson Health invests $50M in research collaborations, teams up with Broad Institute to predict risk of cardiovascular disease By Erin Dietsche
Health IT, Diagnostics IBM Watson finding its way into real-world image interpretation By Neil Versel
